Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.

Since individual immunosuppressive agents display pleiotropic arrays of nonimmunologic toxic complications when used at therapeutic concentrations, sy...
791KB Sizes 0 Downloads 0 Views